Figure 3.
Mean plasma concentrations vs. time profiles of ABT-288 after administration of a single oral dose (5 mg) of ABT-288 under fasting and non-fasting (high fat/high calorie breakfast) conditions to healthy subjects. •, 5 mg, fasting; □, 5 mg, non-fasting